THE FUTURE of metabolic-dysfunction associated liver disease (MASLD) was discussed in an insightful session chaired by Hannes Hagström…

Portal hypertension is the major determinant of outcomes in patients with cirrhosis, defined as the presence of a hepatic venous pressure…

NON-COMMUNICABLE diseases (NCD) represent a major global health challenge, with significant mortality and morbidity. Among these…

Among hepatitis B virus (HBV) core antibody positive (cAb+) people with HIV, suppressive HBV treatment, including either tenofovir…

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) experience difficulties in complying with required lifestyle…

Bile acid (BA) receptors like farnesoid X receptor (FXR) and TGR5 have been implicated in liver regeneration.

The following highlights spotlight the latest research in hepatology, featuring studies presented at this year’s EASL Congress….

Another obesity drug could be on its way to the market after Roche announces positive results for its drug in a phase I trial.

Researchers have discovered that the progression of grey matter atrophy in the brain of patients with mild Parkinson’s disease can be predicted using MRI.

Researchers investigate the impact of demographic predictions on AI diagnostic fairness, revealing significant disparities for women and Black patients in chest X-ray screenings.